Short-term surgical outcome and safety of risk reducing salpingo-oophorectomy in BRCA1/2 mutation carriers

• Published in: Maturitas 2010-07, Vol.66 (3), p.310-314
• Main Authors: Kenkhuis, M.J.A, de Bock, G.H, Oude Elferink, P, Arts, H.J.G, Oosterwijk, J.C, Jansen, L, Mourits, M.J.E
• Format: Article
• Language: English
• Subjects: Adult; Aged; Biological and medical sciences; BRCA1; BRCA2; Breast Neoplasms - genetics; Fallopian Tubes - surgery; Female; Female genital diseases; Genes, BRCA1; Genes, BRCA2; Genetic Predisposition to Disease; Gynecology. Andrology. Obstetrics; Humans; Internal Medicine; Length of Stay; Medical sciences; Middle Aged; Mutation; Obesity - epidemiology; Obstetrics and Gynecology; Ovarian cancer; Ovarian Neoplasms - genetics; Ovarian Neoplasms - prevention & control; Ovariectomy - adverse effects; Ovariectomy - methods; Postoperative Complications; Puberal and climacteric disorders (male and female); Risk reducing salpingo-oophorectomy; Surgical complications; Treatment Outcome; Tumors
• ISSN: 0378-5122; 1873-4111
• DOI: 10.1016/j.maturitas.2010.03.018

Abstract Objective Women with a BRCA1/2 mutation or members of a hereditary breast ovarian cancer family (HBOC) have an increased risk of developing ovarian cancer. The only effective strategy to reduce this risk is a risk reducing salpingo-oophorectomy (RRSO). The aim of this study was to evaluate the short-term surgical outcome and safety of a RRSO. Patient and methods Included were all consecutive women with a BRCA1/2 mutation or members of a HBOC family who visited our Family Cancer Clinic between September 1995 and March 2006, and choose for RRSO. Results 159 women were included, of which 97 (61.0%) BRCA1 and 32 (20.1%) BRCA2 mutation carriers, and 30 women of a HBOC family (18.9%). The median age at RRSO was 42.9 years (30.3–61.1) in the BRCA1 group, 48.4 years (33.5–66.9) in the BRCA 2 group and 46.4 (32.8–68.7) years in the HBOC group ( p = 0.02). The median body mass index (BMI) was 24.9 kg/m2 , 30.1% were overweighed (BMI 25–30) and 18.7% were obese (BMI > 30). The RRSO was performed by primary laparoscopy ( n = 154) or laparotomy ( n = 5). Intraoperatively, one (0.6%) major complication occurred and laparoscopy was converted to laparotomy. In one patient (0.6%) a minor complication occurred. Post-operatively five minor complications (3.1%) were observed. Median hospital stay was 1 day (0–13 days). Conclusion Laparoscopic RRSO in BRCA1/2 mutation carriers seems to be a safe procedure with a low intraoperative and post-operative complication rate (1.3% and 3.1% respectively), a low conversion rate (0.6%) and a short median hospital stay (1.0 day ).